Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths

ABSTRACT: Circulating autoantibodies (auto-Abs) neutralizing high concentrations (10 ng/mL, in plasma diluted 1 to 10) of IFN-α and/or -ω are found in about 10% of patients with critical COVID-19 pneumonia, but not in subjects with asymptomatic infections. We detect auto-Abs neutralizing 100-fold lo...

Full description

Autores:
Franco Restrepo, José Luis
Bastard, Paul
Gervais, Adrian
Le Voyer, Tom
Rosain, Jérémie
Philippot, Quentin
Manry, Jérémy
Michailidis, Eleftherios
Hoffmann, Hans Heinrich
Eto, Shohei
Garcia Prat, Marina
Bizien, Lucy
Parra Martínez, Alba
Yang, Rui
Haljasmägi, Liis
Migaud, Mélanie
Särekannu, Karita
Maslovskaja, Julia
de Prost, Nicolas
Tandjaoui Lambiotte, Yacine
Luyt, Charles Edouard
Amador Borrero, Blanca
Gaudet, Alexandre
Poissy, Julien
Morel, Pascal
Richard, Pascale
Cognasse, Fabrice
Troya, Jesus
Trouillet Assant, Sophie
Belot, Alexandre
Saker, Kahina
Garçon, Pierre
Rivière, Jacques
Lagier, Jean Christophe
Gentile, Stéphanie
Rosen, Lindsey B.
Shaw, Elana
Morio, Tomohiro
Tanaka, Junko
Dalmau, David
Tharaux, Pierre Louis
Sene, Damien
Stepanian, Alain
Megarbane, Bruno
Triantafyllia, Vasiliki
Fekkar, Arnaud
Heath, James R.
Anaya, Juan Manuel
Solé Violán, Jordi
Imberti, Luisa
Biondi, Andrea
Bonfanti, Paolo
Castagnoli, Riccardo
Delmonte, Ottavia M.
Zhang, Yu
Snow, Andrew L.
Holland, Steven M.
Biggs, Catherine
Moncada Vélez, Marcela
Arias Sierra, Andrés Augusto
Lorenzo, Lazaro
Boucherit, Soraya
Coulibaly, Boubacar
Anglicheau, Dany
Planas, Anna M
Haerynck, Filomeen
Duvlis, Sotirija
Nussbaum, Robert L.
Ozcelik, Tayfun
Keles, Sevgi
Bousfiha, Ahmed A.
El Bakkouri, Jalila
Ramírez Santana, Carolina
Paul, Stéphane
Pan Hammarström, Qiang
Hammarström, Lennart
Dupont, Annabelle
Kurolap, Alina
Metz, Christine N.
Aiuti, Alessandro
AlKhater, Suzan
Arrestier, Romain
Baris Feldman, Hagit
Barreiros, Lucila A.
Bilguvar, Kaya
Boyarchuk, Oksana
Bourke, Nollaig M.
Burrel, Sonia
Casari, Giorgio
Chauvineau Grenier, Angélique
Ciceri, Fabio
Condino Neto, Antonio
Coulongeat, Matthieu
Czerkowicz, Jakub
Darragh, Duffy
Domínguez Garrido, Elena
Dorgham, Karim
Dyer, Adam H.
Fellay, Jacques
Gilardin, Laurent
Hagin, David
Halwani, Rabih
Isabelle, Meyts
Joost, Wauters
Kann, Nelli Y
Karakaya, Mahmut
Klocperk, Adam
Lampasona, Vito
Lau, Yu Lung
Leung, Daniel
Lifton, Richard P.
Loreto, Vidaur
Lucie, Roussel
Marlet, Julien
Mehlal, Sedkaoui Souad
Nussenzweig, Michel C
Miyuki, Tsumura
Monneret, Guillaume
Morandeira, Francisco
Narjes Saheb, Sharif-Askari
Prando, Carolina
Quintana Murci, Lluis
Rigo Bonnin, Raúl
Reyes, Luis Felipe
Rye Ostrowski, Sisse
Saheb, Sharif-Askari Narjes
Sahanic, Sabina
Sallette, Jérome
Kennelly, Sean P.
Shcherbina, Anna
Shrikant, Mane
Spaan, András N.
Stepanovskyy, Yurii
Tangye, Stuart G
Tancevski, Ivan
Venet, Fabienne
Vidigal, Mateus
Vinh, Donald C.
Wauters, Joost
Nukui, Yoko
Tipo de recurso:
Article of investigation
Fecha de publicación:
2021
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/40974
Acceso en línea:
https://hdl.handle.net/10495/40974
Palabra clave:
Antibodies, Neutralizing
Anticuerpos Neutralizantes
Autoantibodies
Autoanticuerpos
COVID-19
Case-Control Studies
Estudios de Casos y Controles
Critical Illness
Enfermedad Crítica
Immunoglobulin G
Immunoglobulina G
Interferon Type I
Interferón Tipo I
Interferon-alpha
Interferón-alfa
Aged, 80 and over
Anciano de 80 o más Años
Middle Aged
Persona de Mediana Edad
https://id.nlm.nih.gov/mesh/D057134
https://id.nlm.nih.gov/mesh/D001323
https://id.nlm.nih.gov/mesh/D000086382
https://id.nlm.nih.gov/mesh/D016022
https://id.nlm.nih.gov/mesh/D016638
https://id.nlm.nih.gov/mesh/D007074
https://id.nlm.nih.gov/mesh/D007370
https://id.nlm.nih.gov/mesh/D007370
https://id.nlm.nih.gov/mesh/D016898
https://id.nlm.nih.gov/mesh/D000369
https://id.nlm.nih.gov/mesh/D008875
Rights
openAccess
License
https://creativecommons.org/licenses/by/4.0/
id UDEA2_da935b601f6108cbd22d603c3c8dd097
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/40974
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths
title Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths
spellingShingle Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths
Antibodies, Neutralizing
Anticuerpos Neutralizantes
Autoantibodies
Autoanticuerpos
COVID-19
Case-Control Studies
Estudios de Casos y Controles
Critical Illness
Enfermedad Crítica
Immunoglobulin G
Immunoglobulina G
Interferon Type I
Interferón Tipo I
Interferon-alpha
Interferón-alfa
Aged, 80 and over
Anciano de 80 o más Años
Middle Aged
Persona de Mediana Edad
https://id.nlm.nih.gov/mesh/D057134
https://id.nlm.nih.gov/mesh/D001323
https://id.nlm.nih.gov/mesh/D000086382
https://id.nlm.nih.gov/mesh/D016022
https://id.nlm.nih.gov/mesh/D016638
https://id.nlm.nih.gov/mesh/D007074
https://id.nlm.nih.gov/mesh/D007370
https://id.nlm.nih.gov/mesh/D007370
https://id.nlm.nih.gov/mesh/D016898
https://id.nlm.nih.gov/mesh/D000369
https://id.nlm.nih.gov/mesh/D008875
title_short Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths
title_full Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths
title_fullStr Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths
title_full_unstemmed Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths
title_sort Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths
dc.creator.fl_str_mv Franco Restrepo, José Luis
Bastard, Paul
Gervais, Adrian
Le Voyer, Tom
Rosain, Jérémie
Philippot, Quentin
Manry, Jérémy
Michailidis, Eleftherios
Hoffmann, Hans Heinrich
Eto, Shohei
Garcia Prat, Marina
Bizien, Lucy
Parra Martínez, Alba
Yang, Rui
Haljasmägi, Liis
Migaud, Mélanie
Särekannu, Karita
Maslovskaja, Julia
de Prost, Nicolas
Tandjaoui Lambiotte, Yacine
Luyt, Charles Edouard
Amador Borrero, Blanca
Gaudet, Alexandre
Poissy, Julien
Morel, Pascal
Richard, Pascale
Cognasse, Fabrice
Troya, Jesus
Trouillet Assant, Sophie
Belot, Alexandre
Saker, Kahina
Garçon, Pierre
Rivière, Jacques
Lagier, Jean Christophe
Gentile, Stéphanie
Rosen, Lindsey B.
Shaw, Elana
Morio, Tomohiro
Tanaka, Junko
Dalmau, David
Tharaux, Pierre Louis
Sene, Damien
Stepanian, Alain
Megarbane, Bruno
Triantafyllia, Vasiliki
Fekkar, Arnaud
Heath, James R.
Anaya, Juan Manuel
Solé Violán, Jordi
Imberti, Luisa
Biondi, Andrea
Bonfanti, Paolo
Castagnoli, Riccardo
Delmonte, Ottavia M.
Zhang, Yu
Snow, Andrew L.
Holland, Steven M.
Biggs, Catherine
Moncada Vélez, Marcela
Arias Sierra, Andrés Augusto
Lorenzo, Lazaro
Boucherit, Soraya
Coulibaly, Boubacar
Anglicheau, Dany
Planas, Anna M
Haerynck, Filomeen
Duvlis, Sotirija
Nussbaum, Robert L.
Ozcelik, Tayfun
Keles, Sevgi
Bousfiha, Ahmed A.
El Bakkouri, Jalila
Ramírez Santana, Carolina
Paul, Stéphane
Pan Hammarström, Qiang
Hammarström, Lennart
Dupont, Annabelle
Kurolap, Alina
Metz, Christine N.
Aiuti, Alessandro
AlKhater, Suzan
Arrestier, Romain
Baris Feldman, Hagit
Barreiros, Lucila A.
Bilguvar, Kaya
Boyarchuk, Oksana
Bourke, Nollaig M.
Burrel, Sonia
Casari, Giorgio
Chauvineau Grenier, Angélique
Ciceri, Fabio
Condino Neto, Antonio
Coulongeat, Matthieu
Czerkowicz, Jakub
Darragh, Duffy
Domínguez Garrido, Elena
Dorgham, Karim
Dyer, Adam H.
Fellay, Jacques
Gilardin, Laurent
Hagin, David
Halwani, Rabih
Isabelle, Meyts
Joost, Wauters
Kann, Nelli Y
Karakaya, Mahmut
Klocperk, Adam
Lampasona, Vito
Lau, Yu Lung
Leung, Daniel
Lifton, Richard P.
Loreto, Vidaur
Lucie, Roussel
Marlet, Julien
Mehlal, Sedkaoui Souad
Nussenzweig, Michel C
Miyuki, Tsumura
Monneret, Guillaume
Morandeira, Francisco
Narjes Saheb, Sharif-Askari
Prando, Carolina
Quintana Murci, Lluis
Rigo Bonnin, Raúl
Reyes, Luis Felipe
Rye Ostrowski, Sisse
Saheb, Sharif-Askari Narjes
Sahanic, Sabina
Sallette, Jérome
Kennelly, Sean P.
Shcherbina, Anna
Shrikant, Mane
Spaan, András N.
Stepanovskyy, Yurii
Tangye, Stuart G
Tancevski, Ivan
Venet, Fabienne
Vidigal, Mateus
Vinh, Donald C.
Wauters, Joost
Nukui, Yoko
dc.contributor.author.none.fl_str_mv Franco Restrepo, José Luis
Bastard, Paul
Gervais, Adrian
Le Voyer, Tom
Rosain, Jérémie
Philippot, Quentin
Manry, Jérémy
Michailidis, Eleftherios
Hoffmann, Hans Heinrich
Eto, Shohei
Garcia Prat, Marina
Bizien, Lucy
Parra Martínez, Alba
Yang, Rui
Haljasmägi, Liis
Migaud, Mélanie
Särekannu, Karita
Maslovskaja, Julia
de Prost, Nicolas
Tandjaoui Lambiotte, Yacine
Luyt, Charles Edouard
Amador Borrero, Blanca
Gaudet, Alexandre
Poissy, Julien
Morel, Pascal
Richard, Pascale
Cognasse, Fabrice
Troya, Jesus
Trouillet Assant, Sophie
Belot, Alexandre
Saker, Kahina
Garçon, Pierre
Rivière, Jacques
Lagier, Jean Christophe
Gentile, Stéphanie
Rosen, Lindsey B.
Shaw, Elana
Morio, Tomohiro
Tanaka, Junko
Dalmau, David
Tharaux, Pierre Louis
Sene, Damien
Stepanian, Alain
Megarbane, Bruno
Triantafyllia, Vasiliki
Fekkar, Arnaud
Heath, James R.
Anaya, Juan Manuel
Solé Violán, Jordi
Imberti, Luisa
Biondi, Andrea
Bonfanti, Paolo
Castagnoli, Riccardo
Delmonte, Ottavia M.
Zhang, Yu
Snow, Andrew L.
Holland, Steven M.
Biggs, Catherine
Moncada Vélez, Marcela
Arias Sierra, Andrés Augusto
Lorenzo, Lazaro
Boucherit, Soraya
Coulibaly, Boubacar
Anglicheau, Dany
Planas, Anna M
Haerynck, Filomeen
Duvlis, Sotirija
Nussbaum, Robert L.
Ozcelik, Tayfun
Keles, Sevgi
Bousfiha, Ahmed A.
El Bakkouri, Jalila
Ramírez Santana, Carolina
Paul, Stéphane
Pan Hammarström, Qiang
Hammarström, Lennart
Dupont, Annabelle
Kurolap, Alina
Metz, Christine N.
Aiuti, Alessandro
AlKhater, Suzan
Arrestier, Romain
Baris Feldman, Hagit
Barreiros, Lucila A.
Bilguvar, Kaya
Boyarchuk, Oksana
Bourke, Nollaig M.
Burrel, Sonia
Casari, Giorgio
Chauvineau Grenier, Angélique
Ciceri, Fabio
Condino Neto, Antonio
Coulongeat, Matthieu
Czerkowicz, Jakub
Darragh, Duffy
Domínguez Garrido, Elena
Dorgham, Karim
Dyer, Adam H.
Fellay, Jacques
Gilardin, Laurent
Hagin, David
Halwani, Rabih
Isabelle, Meyts
Joost, Wauters
Kann, Nelli Y
Karakaya, Mahmut
Klocperk, Adam
Lampasona, Vito
Lau, Yu Lung
Leung, Daniel
Lifton, Richard P.
Loreto, Vidaur
Lucie, Roussel
Marlet, Julien
Mehlal, Sedkaoui Souad
Nussenzweig, Michel C
Miyuki, Tsumura
Monneret, Guillaume
Morandeira, Francisco
Narjes Saheb, Sharif-Askari
Prando, Carolina
Quintana Murci, Lluis
Rigo Bonnin, Raúl
Reyes, Luis Felipe
Rye Ostrowski, Sisse
Saheb, Sharif-Askari Narjes
Sahanic, Sabina
Sallette, Jérome
Kennelly, Sean P.
Shcherbina, Anna
Shrikant, Mane
Spaan, András N.
Stepanovskyy, Yurii
Tangye, Stuart G
Tancevski, Ivan
Venet, Fabienne
Vidigal, Mateus
Vinh, Donald C.
Wauters, Joost
Nukui, Yoko
dc.contributor.researchgroup.spa.fl_str_mv Inmunodeficiencias Primarias
dc.subject.decs.none.fl_str_mv Antibodies, Neutralizing
Anticuerpos Neutralizantes
Autoantibodies
Autoanticuerpos
COVID-19
Case-Control Studies
Estudios de Casos y Controles
Critical Illness
Enfermedad Crítica
Immunoglobulin G
Immunoglobulina G
Interferon Type I
Interferón Tipo I
Interferon-alpha
Interferón-alfa
Aged, 80 and over
Anciano de 80 o más Años
Middle Aged
Persona de Mediana Edad
topic Antibodies, Neutralizing
Anticuerpos Neutralizantes
Autoantibodies
Autoanticuerpos
COVID-19
Case-Control Studies
Estudios de Casos y Controles
Critical Illness
Enfermedad Crítica
Immunoglobulin G
Immunoglobulina G
Interferon Type I
Interferón Tipo I
Interferon-alpha
Interferón-alfa
Aged, 80 and over
Anciano de 80 o más Años
Middle Aged
Persona de Mediana Edad
https://id.nlm.nih.gov/mesh/D057134
https://id.nlm.nih.gov/mesh/D001323
https://id.nlm.nih.gov/mesh/D000086382
https://id.nlm.nih.gov/mesh/D016022
https://id.nlm.nih.gov/mesh/D016638
https://id.nlm.nih.gov/mesh/D007074
https://id.nlm.nih.gov/mesh/D007370
https://id.nlm.nih.gov/mesh/D007370
https://id.nlm.nih.gov/mesh/D016898
https://id.nlm.nih.gov/mesh/D000369
https://id.nlm.nih.gov/mesh/D008875
dc.subject.meshuri.none.fl_str_mv https://id.nlm.nih.gov/mesh/D057134
https://id.nlm.nih.gov/mesh/D001323
https://id.nlm.nih.gov/mesh/D000086382
https://id.nlm.nih.gov/mesh/D016022
https://id.nlm.nih.gov/mesh/D016638
https://id.nlm.nih.gov/mesh/D007074
https://id.nlm.nih.gov/mesh/D007370
https://id.nlm.nih.gov/mesh/D007370
https://id.nlm.nih.gov/mesh/D016898
https://id.nlm.nih.gov/mesh/D000369
https://id.nlm.nih.gov/mesh/D008875
description ABSTRACT: Circulating autoantibodies (auto-Abs) neutralizing high concentrations (10 ng/mL, in plasma diluted 1 to 10) of IFN-α and/or -ω are found in about 10% of patients with critical COVID-19 pneumonia, but not in subjects with asymptomatic infections. We detect auto-Abs neutralizing 100-fold lower, more physiological, concentrations of IFN-α and/or -ω (100 pg/mL, in 1/10 dilutions of plasma) in 13.6% of 3,595 patients with critical COVID-19, including 21% of 374 patients > 80 years, and 6.5% of 522 patients with severe COVID-19. These antibodies are also detected in 18% of the 1,124 deceased patients (aged 20 days-99 years; mean: 70 years). Moreover, another 1.3% of patients with critical COVID-19 and 0.9% of the deceased patients have auto-Abs neutralizing high concentrations of IFN-β. We also show, in a sample of 34,159 uninfected subjects from the general population, that auto-Abs neutralizing high concentrations of IFN-α and/or -ω are present in 0.18% of individuals between 18 and 69 years, 1.1% between 70 and 79 years, and 3.4% >80 years. Moreover, the proportion of subjects carrying auto-Abs neutralizing lower concentrations is greater in a subsample of 10,778 uninfected individuals: 1% of individuals <70 years, 2.3% between 70 and 80 years, and 6.3% >80 years. By contrast, auto-Abs neutralizing IFN-β do not become more frequent with age. Auto-Abs neutralizing type I IFNs predate SARS-CoV-2 infection and sharply increase in prevalence after the age of 70 years. They account for about 20% of both critical COVID-19 cases in the over-80s, and total fatal COVID-19 cases.
publishDate 2021
dc.date.issued.none.fl_str_mv 2021
dc.date.accessioned.none.fl_str_mv 2024-08-04T23:29:34Z
dc.date.available.none.fl_str_mv 2024-08-04T23:29:34Z
dc.type.spa.fl_str_mv Artículo de investigación
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.citation.spa.fl_str_mv Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann HH, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Haljasmägi L, Migaud M, Särekannu K, Maslovskaja J, de Prost N, Tandjaoui-Lambiotte Y, Luyt CE, Amador-Borrero B, Gaudet A, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier JC, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux PL, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya JM, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs C, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, El Bakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, van de Beek D, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau YL, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Venet F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino-Neto A, Prando C, Bonradenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S; HGID Lab; COVID Clinicians; COVID-STORM Clinicians; NIAID Immune Response to COVID Group; NH-COVAIR Study Group; Danish CHGE; Danish Blood Donor Study; St. James's Hospital; SARS CoV2 Interest group; French COVID Cohort Study Group; Imagine COVID-Group; Milieu Intérieur Consortium; CoV-Contact Cohort; Amsterdam UMC Covid-19; Biobank Investigators; COVID Human Genetic Effort; CONSTANCES cohort; 3C-Dijon Study; Cerba Health-Care; Etablissement du Sang study group; Anderson MS, Boisson B, Béziat V, Zhang SY, Vandreakos E, Hermine O, Pujol A, Peterson P, Mogensen TH, Rowen L, Mond J, Debette S, de Lamballerie X, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova JL. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. 2021 Aug 19;6(62):eabl4340. doi: 10.1126/sciimmunol.abl4340.
dc.identifier.issn.none.fl_str_mv 2470-9468
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/10495/40974
dc.identifier.doi.none.fl_str_mv 10.1126/sciimmunol.abl4340
identifier_str_mv Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann HH, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Haljasmägi L, Migaud M, Särekannu K, Maslovskaja J, de Prost N, Tandjaoui-Lambiotte Y, Luyt CE, Amador-Borrero B, Gaudet A, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier JC, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux PL, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya JM, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs C, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, El Bakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, van de Beek D, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau YL, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Venet F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino-Neto A, Prando C, Bonradenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S; HGID Lab; COVID Clinicians; COVID-STORM Clinicians; NIAID Immune Response to COVID Group; NH-COVAIR Study Group; Danish CHGE; Danish Blood Donor Study; St. James's Hospital; SARS CoV2 Interest group; French COVID Cohort Study Group; Imagine COVID-Group; Milieu Intérieur Consortium; CoV-Contact Cohort; Amsterdam UMC Covid-19; Biobank Investigators; COVID Human Genetic Effort; CONSTANCES cohort; 3C-Dijon Study; Cerba Health-Care; Etablissement du Sang study group; Anderson MS, Boisson B, Béziat V, Zhang SY, Vandreakos E, Hermine O, Pujol A, Peterson P, Mogensen TH, Rowen L, Mond J, Debette S, de Lamballerie X, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova JL. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. 2021 Aug 19;6(62):eabl4340. doi: 10.1126/sciimmunol.abl4340.
2470-9468
10.1126/sciimmunol.abl4340
url https://hdl.handle.net/10495/40974
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv Sci Immunol
dc.relation.citationendpage.spa.fl_str_mv 26
dc.relation.citationissue.spa.fl_str_mv 62
dc.relation.citationstartpage.spa.fl_str_mv 1
dc.relation.citationvolume.spa.fl_str_mv 6
dc.relation.ispartofjournal.spa.fl_str_mv Science immunology
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by/4.0/
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by/2.5/co/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0/
http://creativecommons.org/licenses/by/2.5/co/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.extent.spa.fl_str_mv 26 páginas
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv American Association for the Advancement of Science
dc.publisher.place.spa.fl_str_mv Washington, Estados Unidos
institution Universidad de Antioquia
bitstream.url.fl_str_mv https://bibliotecadigital.udea.edu.co/bitstreams/7cee875d-b11a-4d78-83d5-d1609a5d6a16/download
https://bibliotecadigital.udea.edu.co/bitstreams/5cb60e02-5fe3-450f-bebb-6de54e3937c2/download
https://bibliotecadigital.udea.edu.co/bitstreams/50d6a36a-a5c5-4f1b-af17-cf9cd6d20357/download
https://bibliotecadigital.udea.edu.co/bitstreams/5158f25a-3315-425c-b994-21ba89552ce7/download
https://bibliotecadigital.udea.edu.co/bitstreams/dee319e1-93d7-4b4a-a934-f5adb4886b41/download
bitstream.checksum.fl_str_mv 8a4605be74aa9ea9d79846c1fba20a33
59638b361cbf0b8cbef0fe1c8f8a7fe2
1646d1f6b96dbbbc38035efc9239ac9c
ba183dd22278190c27b11e3c42b2cdc6
bddedb53a46d21a2fbe8ecbb5878837c
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional de la Universidad de Antioquia
repository.mail.fl_str_mv aplicacionbibliotecadigitalbiblioteca@udea.edu.co
_version_ 1851052302597619712
spelling Franco Restrepo, José LuisBastard, PaulGervais, AdrianLe Voyer, TomRosain, JérémiePhilippot, QuentinManry, JérémyMichailidis, EleftheriosHoffmann, Hans HeinrichEto, ShoheiGarcia Prat, MarinaBizien, LucyParra Martínez, AlbaYang, RuiHaljasmägi, LiisMigaud, MélanieSärekannu, KaritaMaslovskaja, Juliade Prost, NicolasTandjaoui Lambiotte, YacineLuyt, Charles EdouardAmador Borrero, BlancaGaudet, AlexandrePoissy, JulienMorel, PascalRichard, PascaleCognasse, FabriceTroya, JesusTrouillet Assant, SophieBelot, AlexandreSaker, KahinaGarçon, PierreRivière, JacquesLagier, Jean ChristopheGentile, StéphanieRosen, Lindsey B.Shaw, ElanaMorio, TomohiroTanaka, JunkoDalmau, DavidTharaux, Pierre LouisSene, DamienStepanian, AlainMegarbane, BrunoTriantafyllia, VasilikiFekkar, ArnaudHeath, James R.Anaya, Juan ManuelSolé Violán, JordiImberti, LuisaBiondi, AndreaBonfanti, PaoloCastagnoli, RiccardoDelmonte, Ottavia M.Zhang, YuSnow, Andrew L.Holland, Steven M.Biggs, CatherineMoncada Vélez, MarcelaArias Sierra, Andrés AugustoLorenzo, LazaroBoucherit, SorayaCoulibaly, BoubacarAnglicheau, DanyPlanas, Anna MHaerynck, FilomeenDuvlis, SotirijaNussbaum, Robert L.Ozcelik, TayfunKeles, SevgiBousfiha, Ahmed A.El Bakkouri, JalilaRamírez Santana, CarolinaPaul, StéphanePan Hammarström, QiangHammarström, LennartDupont, AnnabelleKurolap, AlinaMetz, Christine N.Aiuti, AlessandroAlKhater, SuzanArrestier, RomainBaris Feldman, HagitBarreiros, Lucila A.Bilguvar, KayaBoyarchuk, OksanaBourke, Nollaig M.Burrel, SoniaCasari, GiorgioChauvineau Grenier, AngéliqueCiceri, FabioCondino Neto, AntonioCoulongeat, MatthieuCzerkowicz, JakubDarragh, DuffyDomínguez Garrido, ElenaDorgham, KarimDyer, Adam H.Fellay, JacquesGilardin, LaurentHagin, DavidHalwani, RabihIsabelle, MeytsJoost, WautersKann, Nelli YKarakaya, MahmutKlocperk, AdamLampasona, VitoLau, Yu LungLeung, DanielLifton, Richard P.Loreto, VidaurLucie, RousselMarlet, JulienMehlal, Sedkaoui SouadNussenzweig, Michel CMiyuki, TsumuraMonneret, GuillaumeMorandeira, FranciscoNarjes Saheb, Sharif-AskariPrando, CarolinaQuintana Murci, LluisRigo Bonnin, RaúlReyes, Luis FelipeRye Ostrowski, SisseSaheb, Sharif-Askari NarjesSahanic, SabinaSallette, JéromeKennelly, Sean P.Shcherbina, AnnaShrikant, ManeSpaan, András N.Stepanovskyy, YuriiTangye, Stuart GTancevski, IvanVenet, FabienneVidigal, MateusVinh, Donald C.Wauters, JoostNukui, YokoInmunodeficiencias Primarias2024-08-04T23:29:34Z2024-08-04T23:29:34Z2021Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann HH, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Haljasmägi L, Migaud M, Särekannu K, Maslovskaja J, de Prost N, Tandjaoui-Lambiotte Y, Luyt CE, Amador-Borrero B, Gaudet A, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier JC, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux PL, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya JM, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs C, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, El Bakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, van de Beek D, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau YL, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Venet F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino-Neto A, Prando C, Bonradenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S; HGID Lab; COVID Clinicians; COVID-STORM Clinicians; NIAID Immune Response to COVID Group; NH-COVAIR Study Group; Danish CHGE; Danish Blood Donor Study; St. James's Hospital; SARS CoV2 Interest group; French COVID Cohort Study Group; Imagine COVID-Group; Milieu Intérieur Consortium; CoV-Contact Cohort; Amsterdam UMC Covid-19; Biobank Investigators; COVID Human Genetic Effort; CONSTANCES cohort; 3C-Dijon Study; Cerba Health-Care; Etablissement du Sang study group; Anderson MS, Boisson B, Béziat V, Zhang SY, Vandreakos E, Hermine O, Pujol A, Peterson P, Mogensen TH, Rowen L, Mond J, Debette S, de Lamballerie X, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova JL. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. 2021 Aug 19;6(62):eabl4340. doi: 10.1126/sciimmunol.abl4340.2470-9468https://hdl.handle.net/10495/4097410.1126/sciimmunol.abl4340ABSTRACT: Circulating autoantibodies (auto-Abs) neutralizing high concentrations (10 ng/mL, in plasma diluted 1 to 10) of IFN-α and/or -ω are found in about 10% of patients with critical COVID-19 pneumonia, but not in subjects with asymptomatic infections. We detect auto-Abs neutralizing 100-fold lower, more physiological, concentrations of IFN-α and/or -ω (100 pg/mL, in 1/10 dilutions of plasma) in 13.6% of 3,595 patients with critical COVID-19, including 21% of 374 patients > 80 years, and 6.5% of 522 patients with severe COVID-19. These antibodies are also detected in 18% of the 1,124 deceased patients (aged 20 days-99 years; mean: 70 years). Moreover, another 1.3% of patients with critical COVID-19 and 0.9% of the deceased patients have auto-Abs neutralizing high concentrations of IFN-β. We also show, in a sample of 34,159 uninfected subjects from the general population, that auto-Abs neutralizing high concentrations of IFN-α and/or -ω are present in 0.18% of individuals between 18 and 69 years, 1.1% between 70 and 79 years, and 3.4% >80 years. Moreover, the proportion of subjects carrying auto-Abs neutralizing lower concentrations is greater in a subsample of 10,778 uninfected individuals: 1% of individuals <70 years, 2.3% between 70 and 80 years, and 6.3% >80 years. By contrast, auto-Abs neutralizing IFN-β do not become more frequent with age. Auto-Abs neutralizing type I IFNs predate SARS-CoV-2 infection and sharply increase in prevalence after the age of 70 years. They account for about 20% of both critical COVID-19 cases in the over-80s, and total fatal COVID-19 cases.COL001242626 páginasapplication/pdfengAmerican Association for the Advancement of ScienceWashington, Estados Unidoshttps://creativecommons.org/licenses/by/4.0/http://creativecommons.org/licenses/by/2.5/co/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deathsArtículo de investigaciónhttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionAntibodies, NeutralizingAnticuerpos NeutralizantesAutoantibodiesAutoanticuerposCOVID-19Case-Control StudiesEstudios de Casos y ControlesCritical IllnessEnfermedad CríticaImmunoglobulin GImmunoglobulina GInterferon Type IInterferón Tipo IInterferon-alphaInterferón-alfaAged, 80 and overAnciano de 80 o más AñosMiddle AgedPersona de Mediana Edadhttps://id.nlm.nih.gov/mesh/D057134https://id.nlm.nih.gov/mesh/D001323https://id.nlm.nih.gov/mesh/D000086382https://id.nlm.nih.gov/mesh/D016022https://id.nlm.nih.gov/mesh/D016638https://id.nlm.nih.gov/mesh/D007074https://id.nlm.nih.gov/mesh/D007370https://id.nlm.nih.gov/mesh/D007370https://id.nlm.nih.gov/mesh/D016898https://id.nlm.nih.gov/mesh/D000369https://id.nlm.nih.gov/mesh/D008875Sci Immunol266216Science immunologyPublicationLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstreams/7cee875d-b11a-4d78-83d5-d1609a5d6a16/download8a4605be74aa9ea9d79846c1fba20a33MD53falseAnonymousREADORIGINALFrancoJose_2021_Autoantibodies_Neutralizing_IFNs.pdfFrancoJose_2021_Autoantibodies_Neutralizing_IFNs.pdfArtículo de investigaciónapplication/pdf4510295https://bibliotecadigital.udea.edu.co/bitstreams/5cb60e02-5fe3-450f-bebb-6de54e3937c2/download59638b361cbf0b8cbef0fe1c8f8a7fe2MD51trueAnonymousREADCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8927https://bibliotecadigital.udea.edu.co/bitstreams/50d6a36a-a5c5-4f1b-af17-cf9cd6d20357/download1646d1f6b96dbbbc38035efc9239ac9cMD52falseAnonymousREADTEXTFrancoJose_2021_Autoantibodies_Neutralizing_IFNs.pdf.txtFrancoJose_2021_Autoantibodies_Neutralizing_IFNs.pdf.txtExtracted texttext/plain103813https://bibliotecadigital.udea.edu.co/bitstreams/5158f25a-3315-425c-b994-21ba89552ce7/downloadba183dd22278190c27b11e3c42b2cdc6MD54falseAnonymousREADTHUMBNAILFrancoJose_2021_Autoantibodies_Neutralizing_IFNs.pdf.jpgFrancoJose_2021_Autoantibodies_Neutralizing_IFNs.pdf.jpgGenerated Thumbnailimage/jpeg21448https://bibliotecadigital.udea.edu.co/bitstreams/dee319e1-93d7-4b4a-a934-f5adb4886b41/downloadbddedb53a46d21a2fbe8ecbb5878837cMD55falseAnonymousREAD10495/40974oai:bibliotecadigital.udea.edu.co:10495/409742025-03-26 20:12:51.495https://creativecommons.org/licenses/by/4.0/open.accesshttps://bibliotecadigital.udea.edu.coRepositorio Institucional de la Universidad de Antioquiaaplicacionbibliotecadigitalbiblioteca@udea.edu.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